Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Bay Area Biotech Launches With $33 Million and Could Double Its Headcount by Next Year

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks4.jpg" NAME"Bay Area Biotech Surrozen Launches With $33 Million and Could Double Its Headcount by Next Year" ALT"Bay Area Biotech Surrozen Launches With $33 Million and Could Double Its…

Continue ReadingBay Area Biotech Launches With $33 Million and Could Double Its Headcount by Next Year

Questions Remain Over Suicide Death of Genentech Lobbyist

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-genentech.jpg" NAME"Questions Remain Over Suicide Death of Genentech Lobbyist" ALT"Questions Remain Over Suicide Death of Genentech Lobbyist"February 15, 2017By Alex Keown, BioSpace.com Breaking News StaffWASHINGTON... Source: BioSpace

Continue ReadingQuestions Remain Over Suicide Death of Genentech Lobbyist

Another Drug Bites the Dust: Merck & Co. Stops Late-Stage Alzheimer???s Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-merck.jpg" NAME"Another Drug Bites the Dust: Merck & Co. Stops Late-Stage Alzheimers Study" ALT"Another Drug Bites the Dust: Merck & Co. Stops Late-Stage Alzheimers Study"February 15, 2017By Alex Keown,…

Continue ReadingAnother Drug Bites the Dust: Merck & Co. Stops Late-Stage Alzheimer???s Study